UBE2F can pair with RBX2 to activate the ligase CRL5 by forming a UBE2F/RBX2/cullin5 complex, leading to the enrichment of NOXA, thereby participating in apoptosis progression and inhibiting cancer cell growth [89]. The gene discussed is UBE2F; the disease is cancer.